Literature DB >> 35697955

Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center.

Shruti Zaveri1, Daniella Nevid2, Meng Ru3, Erin Moshier3, Kereeti Pisapati2, Sylvia A Reyes2, Elisa Port2, Anya Romanoff4,5.   

Abstract

BACKGROUND: Racial disparities in breast cancer care have been linked to treatment delays. We explored whether receiving care at a comprehensive breast center could mitigate disparities in time to treatment.
METHODS: Retrospective chart review identified breast cancer patients who underwent surgery from 2012 to 2018 at a comprehensive breast center. Time-to-treatment intervals were compared among self-identified racial and ethnic groups by negative binomial regression models.
RESULTS: Overall, 2094 women met the inclusion criteria: 1242 (59%) White, 262 (13%) Black, 302 (14%) Hispanic, 105 (5%) Asian, and 183 (9%) other race or ethnicity. Black and Hispanic patients more often had Medicaid insurance, higher American Society of Anesthesiologists (ASA) scores, advanced-stage breast cancer, mastectomy, and additional imaging after breast center presentation (p < 0.05). After controlling for other variables, racial or ethnic minority groups had consistently longer intervals to treatment, with Black women experiencing the greatest disparity (incidence rate ratio 1.42). Time from initial comprehensive breast center visit to treatment was also significantly shorter in White patients versus non-White patients (p < 0.0001). Black race, Medicaid insurance/being uninsured, older age, earlier stage, higher ASA score, undergoing mastectomy, having reconstruction, and requiring additional pretreatment work-up were associated with a longer time from initial visit at the comprehensive breast center to treatment on multivariable analysis (p < 0.05).
CONCLUSION: Racial or ethnic minority groups have significant delays in treatment even when receiving care at a comprehensive breast center. Influential factors include insurance delays and necessity of additional pretreatment work-up. Specific policies are needed to address system barriers in treatment access.
© 2022. Society of Surgical Oncology.

Entities:  

Mesh:

Year:  2022        PMID: 35697955     DOI: 10.1245/s10434-022-11971-w

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   4.339


  7 in total

Review 1.  Effectiveness of Patient Navigation to Increase Cancer Screening in Populations Adversely Affected by Health Disparities: a Meta-analysis.

Authors:  Heidi D Nelson; Amy Cantor; Jesse Wagner; Rebecca Jungbauer; Rongwei Fu; Karli Kondo; Lucy Stillman; Ana Quiñones
Journal:  J Gen Intern Med       Date:  2020-07-22       Impact factor: 5.128

2.  Oncology Navigation Decreases Time to Treatment in Patients with Pancreatic Malignancy.

Authors:  Laura M Enomoto; Joyce Fenstermaker; Rodwige J Desnoyers; Boris C Pasche; A William Blackstock; Russell M Howerton; Clancy J Clark; Edward A Levine; Perry Shen
Journal:  Ann Surg Oncol       Date:  2019-01-16       Impact factor: 5.344

Review 3.  The impact of medical interpreter services on the quality of health care: a systematic review.

Authors:  Glenn Flores
Journal:  Med Care Res Rev       Date:  2005-06       Impact factor: 3.929

4.  Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity.

Authors:  Erlyn C Smith; Argyrios Ziogas; Hoda Anton-Culver
Journal:  JAMA Surg       Date:  2013-06       Impact factor: 14.766

5.  Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer.

Authors:  Dawn L Hershman; Donna Buono; Judith S Jacobson; Russell B McBride; Wei Yann Tsai; Kathie Ann Joseph; Alfred I Neugut
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

6.  Developing a comprehensive breast center.

Authors:  J K Harness; R H Bartlett; P A Saran; M A Bord; W C Noble
Journal:  Am Surg       Date:  1987-08       Impact factor: 0.688

7.  Conceptualizing, Contextualizing, and Operationalizing Race in Quantitative Health Sciences Research.

Authors:  Elle Lett; Emmanuella Asabor; Sourik Beltrán; Ashley Michelle Cannon; Onyebuchi A Arah
Journal:  Ann Fam Med       Date:  2022-01-19       Impact factor: 5.166

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.